N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

C43H56F2N12O5 — CID 164596418

IUPACN-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCc1nn([C@@H]2CC[C@@H](O)N[C@@H]2O)c2cccc(OCCCN3CCN(CC4CCC(n5cc(NC(=O)c6c(N7C[C@H]8C[C@@H]7CO8)nn7cccnc67)c(C(F)F)n5)CC4)CC3)c12
InChIInChI=1S/C43H56F2N12O5/c1-26-36-32(57(49-26)33-11-12-35(58)48-42(33)59)5-2-6-34(36)61-20-4-14-52-16-18-53(19-17-52)22-27-7-9-28(10-8-27)56-24-31(38(50-56)39(44)45)47-43(60)37-40-46-13-3-15-55(40)51-41(37)54-23-30-21-29(54)25-62-30/h2-3,5-6,13,15,24,27-30,33,35,39,42,48,58-59H,4,7-12,14,16-23,25H2,1H3,(H,47,60)/t27?,28?,29-,30-,33-,35-,42-/m1/s1
InChIKeyRYTGVYFNOBCGRV-QINWZKITSA-N
MW859.00 g/mol
LogP4.13
Rot. Bonds13

About N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 164596418) has the molecular formula C43H56F2N12O5 and a molecular weight of 859.00 g/mol. Its IUPAC name is N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID164596418
Molecular FormulaC43H56F2N12O5
Molecular Weight859.00 g/mol
Exact Mass858.45
IUPAC NameN-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCc1nn([C@@H]2CC[C@@H](O)N[C@@H]2O)c2cccc(OCCCN3CCN(CC4CCC(n5cc(NC(=O)c6c(N7C[C@H]8C[C@@H]7CO8)nn7cccnc67)c(C(F)F)n5)CC4)CC3)c12
InChIInChI=1S/C43H56F2N12O5/c1-26-36-32(57(49-26)33-11-12-35(58)48-42(33)59)5-2-6-34(36)61-20-4-14-52-16-18-53(19-17-52)22-27-7-9-28(10-8-27)56-24-31(38(50-56)39(44)45)47-43(60)37-40-46-13-3-15-55(40)51-41(37)54-23-30-21-29(54)25-62-30/h2-3,5-6,13,15,24,27-30,33,35,39,42,48,58-59H,4,7-12,14,16-23,25H2,1H3,(H,47,60)/t27?,28?,29-,30-,33-,35-,42-/m1/s1
InChIKeyRYTGVYFNOBCGRV-QINWZKITSA-N
XLogP4.13
TPSA175.60 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds13
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500859.00
LogP ≤ 54.13
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 164596418) is N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is Cc1nn([C@@H]2CC[C@@H](O)N[C@@H]2O)c2cccc(OCCCN3CCN(CC4CCC(n5cc(NC(=O)c6c(N7C[C@H]8C[C@@H]7CO8)nn7cccnc67)c(C(F)F)n5)CC4)CC3)c12.
What is the InChIKey of N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is RYTGVYFNOBCGRV-QINWZKITSA-N. The full InChI is InChI=1S/C43H56F2N12O5/c1-26-36-32(57(49-26)33-11-12-35(58)48-42(33)59)5-2-6-34(36)61-20-4-14-52-16-18-53(19-17-52)22-27-7-9-28(10-8-27)56-24-31(38(50-56)39(44)45)47-43(60)37-40-46-13-3-15-55(40)51-41(37)54-23-30-21-29(54)25-62-30/h2-3,5-6,13,15,24,27-30,33,35,39,42,48,58-59H,4,7-12,14,16-23,25H2,1H3,(H,47,60)/t27?,28?,29-,30-,33-,35-,42-/m1/s1.
What are the key properties of N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 859.00 g/mol, XLogP of 4.13, 13 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-[(2R,3R,6R)-2,6-dihydroxypiperidin-3-yl]-3-methylindazol-4-yl]oxypropyl]piperazin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 164596418), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).